Effectiveness of abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer in a large prospective real-world cohort: the ABItude study.
Procopio G, Chiuri VE, Giordano M, Mantini G, Maisano R, Bordonaro R, Calvani N, Facchini G, De Placido S, Airoldi M, Sbrana A, Gasparro D, Ludovico GM, Guglielmini P, Naglieri E, Fagnani D, Aglietta M, Schips L, Beccaglia P, Sciarra A, Livi L, Santini D.
Procopio G, et al. Among authors: maisano r.
Ther Adv Med Oncol. 2020 Oct 29;12:1758835920968725. doi: 10.1177/1758835920968725. eCollection 2020.
Ther Adv Med Oncol. 2020.
PMID: 33193831
Free PMC article.